Europass

Curriculum Vitae
Informatii personale
Nume BOJINCA MIHAI

Aplicatie pentru

Experienta profesionala
Date 2007-prezent
PozitieSef sectie Medicina Interna 1, conferentiar universitar.
Activitati si responsabilitati
Diagnosticul si tratamentul pacientilor sectiei. Cursuri si activitate practica cu student si rezidenti
Reumatologie si Medicina Interna
Numele si adresa angajatorului Spital “Dr. I. Cantacuzino”, I. Movila 5 – 7, sector 2, UMF “ Carol Davila”, Dionisie Lupu 47,
sector 2 Bucuresti

Sector de activitate Medicina, educatie medicala

Dates 2004-2007
PozitieSef sectie Medicina Interna 1, sef de lucrari
Activitati si responsabilitati
Diagnosticul si tratamentul pacientilor sectiei. Cursuri si activitate practica cu student si rezidenti
Reumatologie si Medicina Interna
Numele si adresa angajatorului Spital “Dr. I. Cantacuzino”, I. Movila 5 – 7, sector 2, UMF “ Carol Davila”, Dionisie Lupu 47,
sector 2 Bucuresti

Sector de activitate Medicina, educatie medicala.

Date 2000 - 2004

PozitieSef sectie Medicina Interna 1, asistent universitar
Activitati si responsabilitati
Diagnosticul si tratamentul pacientilor sectiei. Cursuri si activitate practica cu student si rezidenti
Reumatologie si Medicina Interna
Numele si adresa angajatorului Spital “Dr. I. Cantacuzino”, I. Movila 5 – 7, sector 2, UMF “ Carol Davila”, Dionisie Lupu 47,
sector 2 Bucuresti

Sector de activitate Medicina, educatie medicala.

Date 1995 - 1999

PozitieMedic specialist, asistent universitar
Activitati si responsabilitati
Diagnosticul si tratamentul pacientilor sectiei. Cursuri si activitate practica cu student si rezidenti
Reumatologie si Medicina Interna
Numele si adresa angajatorului Spital “Dr. I. Cantacuzino”, I. Movila 5 – 7, sector 2, UMF “ Carol Davila”, Dionisie Lupu 47,
sector 2 Bucuresti

[Type text]
 Sector de activitate Medicina, educatie medicala.

Educatie si pregatire

Date 2004
Titlu obtinut Medic primar Reumatologie
Numele organizatiei Ministerul Sanatatii

Date 2000
Titlu obtinut Medic primar Medicina Interna, sef sectie Medicina Interna 1

Numele organizatiei Ministerul Sanatatii

Date 1998
Titlu obtinut Medic specialist Reumatologie
Numele organizatiei Ministerul Sanatatii

Date 1995
Titlu obtinut Medic specialist Medicina Interna
Numele organizatiei Ministerul Sanatatii

Date 1990 – 1991, 1991 - 1994

Titlu obtinut Medic stagiar, medic secundar Medicina Interna
Numele organizatiei Spital “Sf. Maria”, Bucuresti

1990
Titlu obtinut Medic
Numele organizatiei UMF “Carol Davila” Bucuresti, Facultatea de Medicina
Activitate stiintifica Autor si co-autor a 3 carti si 6 capitole in monografii si tratate.
Autor si co – autor a peste 45 articole publicate in reviste indexate in baze de date internationale.
Autor si co-autor a peste 30 de articole in reviste listate CNCSIS b+
Autor a peste 100 de lucrari orale si postere la conferinte si congrese nationale si interantionale.

Activitate de cercetare Participant in 2 proiecte de cercetare internationale

Director in 1 PNCDI II Grant 2007 - 2010
Membru in echipa de cercetare a 5 proiecte PNCDI
Investigator principal in peste 30 de studii clinice interantionale.

Aptitudini si competente
Limba materna Romana
Limbi straine Engleza, Franceza
Autoevaluare Intelegere (nivel) Vorbit (nivel) Scris
Engleza Bun Bun Bun
Franceza Bun Bun Bun

[Type text]
 Capacitati organizatorice Sef sectie

Competente Ecografie generala, ecografie musculoscheletala (nivel mediu), densitometrie clinica.

Computer User

Carnet de conducere Category B

Informatii suplimentare
Anexe Lista publicatiilor

LISTA PUBLICATIILOR

Carti publicate

1. M. Bojincă – „Implicaţii imunogenetice în evoluţia poliartritei reumatoide”, Editura Tehnoplast, 2006, Bucureşti, ISBN 973-8932-06-8.
2. V. Bojincă, M. Milicescu, M. Bojincă – „Actualităţi în dignosticul şi tratamentului osteoporozei” – Editura Tehnoplast, 2006 Bucureşti, ISBN
973-8932-01-7.
3. Coautor la “Explorări funcţionale”, autor Stefan Sorin Aramă, Editura Cerma, 2000 Bucureşti, ISBN 973–9266–39-8.

Capitole publicate

1. M. Bojincă, Violeta Bojincă - “Explorări de laborator în bolile conjunctivo-vasculare” în vol. “Explorări funcţionale”, pp.
241-255, Editura Cerma, 2000 Bucureşti, ISBN 973–9266–39-8.
2. Şt. Şuţeanu, P. Ignat, M. Bojincă, Mariana Sasu – „Boala mixtă a ţesutului conjunctiv” Medicina Intern, sub red. L.
Gherasim, vol. I, ed. II, Editura Medicală, Bucureşti 2000, pag. 729-736, ISBN 973–39–0254-3.
3. M. Bojincă – „Aspecte prognostice şi evolutive în poliartrita reumatoidă” , „Îndreptar de expertiză medicală, medicină
de asigurări” sub red. I. Soare, Editura Etna, Bucureşti, 2004, pag. 126-130, ISBN 973-85719-7-9.
4. M. Bojincă – „Aspecte genetice în bolile reumatice”, „Esenţialul în Reumatologie” sub red. R. Ionescu, Editura
Medicală Amaltea, 2006 Bucureşti, ISBN 973-7780-46-9.
5. M. Bojinca – „Artrita precoce, incotro?” – „Artrita precoce” sub red. C. Codreanu, Editura Universitara Carol Davila
2016, ISBN 978-973-708-925-0.
6. M. Bojinca – „Osteoporoza in bolile hematologice” – „Osteoporoza din perspectiva multidisciplinara” sub red. V.
Bojinca, Editura Etna 2017, ISBN 978-973-1985-21-3

7. M. Bojincă – „Autoinflamaţia” – „Mecanismele imune în Reumatologie” sub red. Andra Rodica Bălănescu, Editura
Medicală 2019, ISBN 978-973-39-0853-1

Articole publicate

1. S. Aramă, V. Stoica, M. Bojincă, A. Răşanu. Tratamentul cu infliximab în bolile inflamatorii intestinale, poliartrita
reumatoidă şi spondilita anchilozantă. În: Terapeutică, farmacologie şi toxicologie clinică (2003), VII, 1, pag. 75-82,
ISSN 1583-0012
2. A. Răşanu, V. Stoica, S. Aramă, M. Bojincă. Manifestări digestive în poliartrita reumatoidă, lupusul eritematos
sistemic şi sclerodermie. În: Infomedica (2004), XII, 4, pag. 14-21, ISSN 1221-681x
3. A. Răşanu, S. Aramă, M. Bojincă, V. Stoica. Efecte adverse ale antiinflamatoarelor nesteroidiene în terapia bolilor de
colagen. În: Terapeutică, farmacologie şi toxicologie clinică (2005), IX, 3, pag. 41-51, ISSN 1583-0012 (revistă cotată
CNCSIS C)
4. A. Răşanu, S. Aramă, M. Bojincă, V. Stoica. The digestive side-effects of disease-modifying antirheumatic therapy. În:
Terapeutică, farmacologie şi toxicologie clinică (2005), IX, 4, pag. 11-18, ISSN 1583-0012 (revistă cotată CNCSIS C)
5. A. Răşanu, S. Aramă, M. Bojincă, V. Stoica. Diagnosticul afectării hepatice din bolile de colagen. În: Medicina Mod-
ernă (2006), XIII, 7, pag 345 – 350, ISSN 1223-0472
6. S. Aramă, Alina Răşanu, M. Bojincă, V. Stoica. Afectarea digestivă superioară în bolile de colagen. În: Terapeutică,
farmacologie şi toxicologie clinică (2007), XI, supliment, pag. 12-17, ISSN 1583-0012 (revistă cotată CNCSIS C)
7. A. Răşanu, S. Aramă, M. Bojincă, V. Stoica. Strategii diagnostice privind afectarea tractului digestiv la pacienţii cu boli
de colagen. În: Terapeutică, farmacologie şi toxicologie clinică (2007), XI, supliment, pag. 21-25, ISSN 1583-0012 (re-
vistă cotată CNCSIS C)

[Type text]
8. A. Răşanu, S. Aramă, M. Bojincă, V. Stoica. Strategii diagnostice privind afectarea tractului digestiv la pacienţii cu boli
de colagen. În: Terapeutică, farmacologie şi toxicologie clinică (2007), XI, 1-2, pag. 81-88, ISSN 1583-0012 (revistă
cotată CNCSIS C)
9. M. Bojincă, S. Aramă, V. Bojincă, M. Milicescu, Al. Croitoru, V. Aramă, A. Câmpean. Comparative Study of Matrix
Metalloproteinases in Synovial Fluid from Rheumatoid Arthritis and Arthrosis Patients. În: Rev. Chim. (Bucureşti)
2007; 58, 12, pag. 1327-1331, ISSN 0034-7752 (revistă indexată ISI)
10. Popa, Gheorghe; Ionitescu, Razvan C.; Potorac, Romeo; Mihai, Carina; Bojinca, Mihai; Stoica, Victor, Fingerprints
evaluation in systemic sclerosis. ROMANIAN JOURNAL OF LEGAL MEDICINE, 18 (2), pp. 155-160, 2010.
11. Popa, O. M.; Bojinca, M.; Bojinca, V.; Ciofu, C.; Dutescu, M. I.; Bardan, A.; Sfrent-Cornateanu, R.; Petrek, M.; Bara,
C.; Popa, L., Distribution of HLA-B27 in Romanian spondyloarthritides patients. INTERNATIONAL JOURNAL OF IM-
MUNOGENETICS, 37 (6), pp. 513-516, 2010.
12. Popa, O. M.; Popa, L.; Dutescu, M. I.; Bojinca, M.; Bojinca, V.; Ciofu, C.; Bara, C.; Mrazek, F.; Petrek, M., HLA-C lo-
cus and genetic susceptibility to psoriatic arthritis in Romanian population. TISSUE ANTIGENS, 77 (4), pp. 325-328,
2011.
13. [Link], V; Popescu, CC; Saulescu, IC ; Opris, D; Borangiu, A; Groseanu, L; Balanescu, A; Ionescu, R ; Bojinca, M
. VITAMIN D LEVELS ARE ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY.
FARMACIA Volume: 64 Issue: 3, Pages: 423-429, Published: MAY-JUN 2016. Factor de impact - 1.5070
14. 2. LAURA OLARIU, BRINDUSA DUMITRIU, LUIZA CRACIUN, EMILIA
15. BUSE, NATALIA ROSOIU, *,
MIHAI BOJINCA TOMA PAPACOCEA.
16. THE IN VITRO INFLUENCE OF A PHARMACEUTICALLY ACTIVE SMALL SEA FISH EXTRACT ON APOPTOSIS
AND PROLIFERATION MECHANISMS AMPLIFIED BY INFLAMMATORY CONDITIONS. FARMACIA, 2018, Vol. 66,
3, Pages 524 - 529. Factor de impact - 1,5070. *corresponding author
17. 3. VIOLETA CLAUDIA BOJINCĂ, MIHAI BOJINCĂ, CRISTINA-ILEANA IOSIF, ŞERBAN MIHAI BĂLĂNESCU,
ANDRA RODICA BĂLĂNESCU. Diagnostic challenges in a patient with calciphylaxia – a case report. Rom J Morphol
Embryol 2018, 59(2):591–594. Impact factor - 0.32 . Corresponding author - Mihai Bojincă, Associate Professor,
MD, PhD, Department of Internal Medicine and Rheumatology, “Dr. Ion Cantacuzino” Hospital.
18. 4. SERBAN BALANESCU, VIOLETA BOJINCA, ANDRA BALANESCU, MIHAI BOJINCA. Lipoprotein (a) Biology and
the Role in Cardiovascular Medicine. [Link].(Bucharest), 69; No.8; 2018, pages 1987 - 1991. Factor de impact -
1,412 . All authors have equal contribution.
19. 5. MIHAI BOJINCA, VIOLETA CLAUDIA BOJINCA, ANDRA RODICA BALANESCU, SERBAN MIHAI BALANESCU.
Macro Creatine Kinase (macro CK) in Clinical Practice. [Link].(Bucharest) 69; No.8; 2018, pages 2107 - 2109.
Factor de impact - 1,412 . All authors have equal contribution.
20. 7. ANDRA‐RODICA BĂLĂNESCU, VIOLETA CLAUDIA BOJINCĂ, MIHAI BOJINCĂ, TEODORA DONISAN and
SERBAN MIHAI BĂLĂNESCU. Cardiovascular effects of methotrexate in immune‐mediated inflammatory diseases.
(Review) EXPERIMENTAL AND THERAPEUTIC MEDICINE 17: 1024-1029, 2019. Factor de impact - 1,448. ARB,
VCB, MB, TD and SMB contributed to writing and preparing the manuscript, and collecting the relevant literature. All
authors read and approved the final version of manuscript.
21. 8. VIOLETA BOJINCA, CLAUDIU POPESCU, ANDRA RODICA BALANESCU, SERBAN MIHAI BALANESCU, MIHAI
BOJINCA. Osteoporosis and Bone Metabolism in Treatment-naive Primary Prostate Adenocarcinoma Patients.
[Link].(Bucharest)69; No. 5; 2018pages 1099 - 1105. Factor de impact - 1,412. All authors had equal
contribution .
1,†, 2,†,
22. 9. Olivia M. Popa Mihai Bojinca Violeta Bojinca, Monica I. Dutescu, Mihaela Meirosu, Ruxandra E. Caisan,

Claudia Ciofu, Constantin Bara and Luis O. Popa. A Pilot Study of the Association of Tumor Necrosis Factor Alpha
Polymorphisms with Psoriatic Arthritis in the Romanian Population. 2011, 12, 5052-5059. Factor de impact - 2,598.
† These authors contributed equally to this work.
23. 10. SERBAN BALANESCU, VIOLETA CLAUDIA BOJINCA, ADRIAN IANCU, MIHAI BOJINCA, ANDRA
BALANESCU. Postmenopausal Calcium and Vitamin D Supplements Controversy: Do They Increase Cardiovascular
Risk? [Link].(Bucharest), 69; No. 4; 2018, pages 956 - 960. Factor de impact - 1,412 . All authors had equal
contribution.
24. 11. Sarah Leggett, Antje van der Zee-Neuen, Annelies Boonen, Dorcas E. Beaton, Mihai Bojinca, Ailsa Bosworth,
Sabrina Dadoun, Bruno Fautrel, Sofia Hagel, Catherine Hofstetter,Diane Lacaille, Denise Linton, Carina Mihai,
Ingemar F. Petersson, Pam Rogers,Jamie C. Sergeant, Carlo Sciré, and Suzanne M.M. Verstappen on behalf of the
At-work Productivity Global Measure Working Group. Test-retest Reliability and Correlations of 5 Global Measures
Addressing At-work Productivity Loss in Patients with Rheumatic Diseases. The Journal of Rheumatology 2016; 43:2.
Factor de impact - 3,150
25. Olivia Mihaela Popa, Eva Kriegova, Luis Popa, Petra Schneiderova, Monica Irina Dutescu, Mihai Bojinca,
Constantin Bara, Martin Petrek. Association study in Romanians confirms IL23A gene haplotype block
rs2066808/rs11171806 as conferring risk to psoriatic arthritis. Cytokine 63 (2013) 67–73 Factor de impact - 2,83.
26. M. Cherciu, L. O. Popa, M. Bojinca, M. I. Dutescu, V. Bojinca, C. Bara & O. M. Popa. Functional variants of ERAP1
gene are associated with HLA-B27 positive spondyloarthritis. Tissue Antigens, 2013, 82, 192–196. Factor de impact -
1,38
27. T. Donisan, V. C. Bojincă, M. A. Dobrin, D. V. Bălănescu, D. Predețeanu, M. Bojincă, F. Berghea, D. Opris, L.
[Type text]
 Groșeanu, A. Borangiu,C. L. Constantinescu, R. Ionescu, A. R. Bălănescu. The relationship between disease activity,
quality of life,and personality types in rheumatoid arthritis and ankylosing spondylitis patients. Clinical Rheumatology
2017 36 (7), pp. 1511-1519. Factor de impact - 1,88
28. Soare, A., Gheorghiu, A.M., Aramă, V., Bumbăcea, D., Dobrotă, R., Oneaţă, R., Pintilie, S., Milicescu,M., Ancuţa, I.,
Martin, A., Sasu, M., Ciofu, C., Macovei, L., Stoica, V., Bojincă, M., Mihai, [Link] of active tuberculosis in patients
with inflammatory arthritis receiving TNF inhibitors: a look beyond the baseline tuberculosis screening protocol.
(2018) Clinical Rheumatology, 37 (9), pp. 2391-2397. Factor de impact - 1,47
29. Negrei, C., Bojinca, V., Balanescu, A., Bojinca, M., Baconi, D., Spandidos, D.A., Tsatsakis, A.M., Stan, M.
Management of rheumatoid arthritis: Impact and risks of various therapeutic approaches (Review) (2016)
Experimental and Therapeutic Medicine, 11 (4), pp. 1177-1183. Factor de impact - 0,74
30. Leggett S, van der Zee-Neuen A, Boonen A, Beaton D, Bojinca M, Bosworth A, Dadoun S, Fautrel B, Hagel S,
Hofstetter C, Lacaille D, Linton D, Mihai C, Petersson IF, Rogers P, Sciré C, Verstappen SM; at-work productivity
global measure working group. Content validity of global measures for at-work productivity in patients with rheumatic
diseases: An international qualitative study. Rheumatology (Oxford). 2016 Aug;55(8):1364-73. Impact factor - 2,52
31. VIOLETA-CLAUDIA BOJINCĂ1*, CLAUDIU C. POPESCU2*, RALUCA-DANIELA DECIANU1*, ANDREI
DOBRESCU1*, ȘERBAN MIHAI BĂLĂNESCU3*, ANDRA-RODICA BĂLĂNESCU1* and MIHAI BOJINCĂ4*. A novel
quantitative method for estimating bone mineral density using B-mode ultrasound and radiofrequency signals-a pilot
study on patients with rheumatoid arthritis. EXPERIMENTAL AND THERAPEUTIC MEDICINE. DOI:
10.3892/etm.2019.7746. Factor de impact – 1,448.

PUBMED

1. Sobanski V, Giovannelli J, Allanore Y, Riemekasten G, Airò P, Vettori S, Cozzi

F, Distler O, Matucci-Cerinic M, Denton C, Launay D, Hachulla E; EUSTAR

collaborators. Phenotypes determined by cluster analysis and their survival in
the prospective EUSTAR cohort of patients with systemic sclerosis. Arthritis
Rheumatol. 2019 Apr 10. doi: 10.1002/art.40906. [Epub ahead of print] PubMed
PMID: 30969034.
2. Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Alegre Sancho JJ,

Truchetet ME, Braun-Moscovici Y, Iannone F, Novikov PI, Lescoat A, Siegert E,

Castellví I, Airó P, Vettori S, De Langhe E, Hachulla E, Erler A, Ananieva L,
Krusche M, López-Longo FJ, Distler JHW, Hunzelmann N, Hoffmann-Vold AM, Riccieri
V, Hsu VM, Pozzi MR, Ancuta C, Rosato E, Mihai C, Kuwana M, Saketkoo LA,
Chizzolini C, Hesselstrand R, Ullman S, Yavuz S, Rednic S, Caimmi C,
Bloch-Queyrat C, Allanore Y; for EUSTAR network. Outcomes of patients with
systemic sclerosis treated with rituximab in contemporary practice: a prospective
cohort study. Ann Rheum Dis. 2019 Jul;78(7):979-987.
10.1136/annrheumdis-2018-214816. Epub 2019 Apr 9. PubMed PMID: 30967395.
3. Baicus C, Balanescu P, Gurghean A, Badea CG, Padureanu V, Rezus C, Mitu F,
Jurcut R, Balanescu AR, Daha I, Balanescu E, Bojinca M, Pinte L, Constantin AM,
Dima N, Floria M, Leon-Constantin MM, Roca M, Mitu M, Chiriac S, Badescu CM,
Ionescu SD, Mitrea E, Rosu G, Ionescu GD, Visinescu AM, Mihailescu G, Lapadatu R,
Oprisan E, Zeh S, Scholl I, Härter M. Romanian version of SDM-Q-9 validation in
Internal Medicine and Cardiology setting: a multicentric cross-sectional study.
Rom J Intern Med. 2019 Jun 1;57(2):195-200. doi: 10.2478/rjim-2019-0002. PubMed
PMID: 30721145
[Link] VC, Bojinca M, Gheorghe M, Birceanu A, Iosif CI, Balanescu SM,
Balanescu AR. Stevens-Johnsons syndrome or drug-induced lupus - a clinical
dilemma: A case report and review of the literature. Biomed Rep. 2018
Jul;9(1):37-41. doi: 10.3892/br.2018.1098. Epub 2018 May 16. PubMed PMID:
29930803; PubMed Central PMCID: PMC6007037.
5. Barbu EC, Chițu-Tișu CE, Lazăr M, Olariu C, Bojincă M, Ionescu RA, Ion DA,

Bădărău IA. Hepatic Osteodystrophy: A Global (Re)View of the Problem. Acta Clin
Croat. 2017 Sep;56(3):512-525. doi: 10.20471/acc.2017.56.03.19. Review. PubMed
PMID: 29479918.
6: Popa OM, Cherciu M, Cherciu LI, Dutescu MI, Bojinca M, Bojinca V, Bara C,
Popa LO. ERAP1 and ERAP2 Gene Variations Influence the Risk of Psoriatic
Arthritis in Romanian Population. Arch Immunol Ther Exp (Warsz). 2016
Dec;64(Suppl 1):123-129. doi: 10.1007/s00005-016-0444-4. Epub 2017 Jan 12. PubMed
PMID: 28083616.
7: Chițu-Tișu CE, Barbu EC, Lazăr M, Bojincă M, Tudor AM, Hristea A, Abagiu AO,
Ion DA, Bădărău AI. Body composition in HIV-infected patients receiving highly
[Type text]
active antiretroviral therapy. Acta Clin Belg. 2017 Feb;72(1):55-62. doi:
10.1080/17843286.2016.1240426. Epub 2016 Oct 11. PubMed PMID: 27724840.
8: Barbu EC, Chiţu-Tișu CE, Lazăr M, Olariu CM, Olteanu D, Bojincă M, Abagiu AO,
Aramă V, Ion DA, Bădărău IA. Body Composition Changes in Patients with Chronic
Hepatitis C. J Gastrointestin Liver Dis. 2016 Sep;25(3):323-9. doi:
10.15403/[Link]. PubMed PMID: 27689196.
9: Clowse ME, Wallace DJ, Furie RA, Petri MA, Pike MC, Leszczyński P, Neuwelt
CM, Hobbs K, Keiserman M, Duca L, Kalunian KC, Galateanu C, Bongardt S, Stach C,
Beaudot C, Kilgallen B, Gordon C; EMBODY Investigator Group. Efficacy and Safety
of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus:
Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.
Arthritis Rheumatol. 2017 Feb;69(2):362-375. doi: 10.1002/art.39856. PubMed PMID:
27598855; PubMed Central PMCID: PMC5299488.
10: Cohen AT, Harrington RA, Goldhaber SZ, Hull RD, Wiens BL, Gold A, Hernandez
AF, Gibson CM; APEX Investigators. Extended Thromboprophylaxis with Betrixaban in
Acutely Ill Medical Patients. N Engl J Med. 2016 Aug 11;375(6):534-44. doi:
10.1056/NEJMoa1601747. Epub 2016 May 27. PubMed PMID: 27232649.
11: Dobrota R, Maurer B, Graf N, Jordan S, Mihai C, Kowal-Bielecka O, Allanore Y,
Distler O; EUSTAR coauthors. Prediction of improvement in skin fibrosis in
diffuse cutaneous systemic sclerosis: a EUSTAR analysis. Ann Rheum Dis. 2016
Oct;75(10):1743-8. doi: 10.1136/annrheumdis-2015-208024. Epub 2016 Mar 25. PubMed
PMID: 27016052; PubMed Central PMCID: PMC5036205.
12: Pokorney SD, Piccini JP, Stevens SR, Patel MR, Pieper KS, Halperin JL,
Breithardt G, Singer DE, Hankey GJ, Hacke W, Becker RC, Berkowitz SD, Nessel CC,
Mahaffey KW, Fox KA, Califf RM; ROCKET AF Steering Committee & Investigators;
ROCKET AF Steering Committee Investigators. Cause of Death and Predictors of
All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial
Fibrillation: Data From ROCKET AF. J Am Heart Assoc. 2016 Mar 8;5(3):e002197.
doi: 10.1161/JAHA.115.002197. PubMed PMID: 26955859; PubMed Central PMCID:
PMC4943233.
13: Vlad V, Berghea F, Micu M, Varzaru L, Bojinca M, Milicescu M, Ionescu R,
Naredo E. Tenosynovitis US scoring systems follow synovitis and clinical scoring
systems in RA and are responsive to change after biologic therapy. Med Ultrason.
2015 Sep;17(3):352-60. doi: 10.11152/[Link]. PubMed PMID: 26343085.
14: Ingegnoli F, Boracchi P, Gualtierotti R, Smith V, Cutolo M, Foeldvari I;
EUSTAR co-authors. A comparison between nailfold capillaroscopy patterns in
adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory
study. Microvasc Res. 2015 Nov;102:19-24. doi: 10.1016/[Link].2015.07.007. Epub
2015 Aug 4. PubMed PMID: 26254260.
15: Elhai M, Avouac J, Walker UA, Matucci-Cerinic M, Riemekasten G, Airò P,
Hachulla E, Valentini G, Carreira PE, Cozzi F, Balbir Gurman A, Braun-Moscovici
Y, Damjanov N, Ananieva LP, Scorza R, Jimenez S, Busquets J, Li M, Müller-Ladner
U, Kahan A, Distler O, Allanore Y; EUSTAR co-authors. A gender gap in primary and
secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study.
Ann Rheum Dis. 2016 Jan;75(1):163-9. doi: 10.1136/annrheumdis-2014-206386. Epub
2014 Oct 23. PubMed PMID: 25342760.
16: Maurer B, Graf N, Michel BA, Müller-Ladner U, Czirják L, Denton CP, Tyndall
A, Metzig C, Lanius V, Khanna D, Distler O; EUSTAR co-authors. Prediction of
worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis
using the EUSTAR database. Ann Rheum Dis. 2015 Jun;74(6):1124-31. doi:
10.1136/annrheumdis-2014-205226. Epub 2014 Jun 30. PubMed PMID: 24981642.
17: Oancea C, Mihai C, Gherman D, Milicescu M, Ancuta I, Martin A, Bojinca M,
Stoica V, Ciuvica MM. Development of a prognostic score for work disability in
Romanian patients with ankylosing spondylitis. Disabil Rehabil.
2015;37(6):506-11. doi: 10.3109/09638288.2014.932442. Epub 2014 Jun 26. PubMed
PMID: 24965210.
18: Halperin JL, Hankey GJ, Wojdyla DM, Piccini JP, Lokhnygina Y, Patel MR,
Breithardt G, Singer DE, Becker RC, Hacke W, Paolini JF, Nessel CC, Mahaffey KW,
Califf RM, Fox KA; ROCKET AF Steering Committee and Investigators. Efficacy and
safety of rivaroxaban compared with warfarin among elderly patients with
nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct
Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke
and Embolism Trial in Atrial Fibrillation (ROCKET AF). Circulation. 2014 Jul
8;130(2):138-46. doi: 10.1161/CIRCULATIONAHA.113.005008. Epub 2014 Jun 3. Erratum
[Type text]
in: Circulation. 2018 Dec 18;138(25):e783. PubMed PMID: 24895454.
19: Vlad V, Berghea F, Iagnocco A, Micu M, Damjanov N, Skakic V, Prodanovic S,
Radunovic G, Szkudlarek M, Nestorova R, Petranova T, Kakavouli J, Porta F,
Perricone C, Ciechomska A, Moller I, Varzaru L, Peric P, Dejaco C, Bojinca M,
Fodor D, Milicescu M, Naredo E. Inter & intra-observer reliability of grading
ultrasound videoclips with hand pathology in rheumatoid arthritis by using non-
sophisticated internet tools (LUMINA study). Med Ultrason. 2014 Mar;16(1):32-6.
PubMed PMID: 24567922.
20: Meier FM, Frommer KW, Dinser R, Walker UA, Czirjak L, Denton CP, Allanore Y,
Distler O, Riemekasten G, Valentini G, Müller-Ladner U; EUSTAR Co-authors. Update
on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials
and Research group database. Ann Rheum Dis. 2012 Aug;71(8):1355-60. doi:
10.1136/annrheumdis-2011-200742. Epub 2012 May 21. PubMed PMID: 22615460.
21: Hankey GJ, Patel MR, Stevens SR, Becker RC, Breithardt G, Carolei A, Diener
HC, Donnan GA, Halperin JL, Mahaffey KW, Mas JL, Massaro A, Norrving B, Nessel
CC, Paolini JF, Roine RO, Singer DE, Wong L, Califf RM, Fox KA, Hacke W; ROCKET
AF Steering Committee Investigators. Rivaroxaban compared with warfarin in
patients with atrial fibrillation and previous stroke or transient ischaemic
attack: a subgroup analysis of ROCKET AF. Lancet Neurol. 2012 Apr;11(4):315-22.
doi: 10.1016/S1474-4422(12)70042-X. Epub 2012 Mar 7. PubMed PMID: 22402056.
22: Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G,
Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz
SD, Fox KA, Califf RM; ROCKET AF Investigators. Rivaroxaban versus warfarin in
nonvalvular atrial fibrillation. N Engl J Med. 2011 Sep 8;365(10):883-91. doi:
10.1056/NEJMoa1009638. Epub 2011 Aug 10. PubMed PMID: 21830957.
23: Branco JC, Cherin P, Montagne A, Bouroubi A; Multinational Coordinator Study
Group. Longterm therapeutic response to milnacipran treatment for fibromyalgia. A
European 1-year extension study following a 3-month study. J Rheumatol. 2011
Jul;38(7):1403-12. doi: 10.3899/jrheum.101025. Epub 2011 Apr 1. PubMed PMID:
21459941.
24: Mogoşan C, Stoica V, Mihai C, Ciofu C, Bojincă M, Milicescu M, Crişan V,
Mioara B. Trends of rheumatoid arthritis monitorization in Romania. J Med Life.
2010 Jul-Sep;3(3):330-7. PubMed PMID: 20945825; PubMed Central PMCID: PMC3019003.
25: Mogosan C, Stoica V, Mihai C, Macovei L, Ancuta I, Ciofu C, Stefanescu F,
Bojinca M, Martin A, Milicescu M, Crisan V, Banciu M, Suteanu S. Rheumatoid
arthritis: travelling biological era a Romanian X-ray population. J Med Life.
2009 Oct-Dec;2(4):414-25. PubMed PMID: 20108756; PubMed Central PMCID:
PMC3019021.
26: Grigorescu M; Romanian Society of Gastroenterology and Hepatology. HCV
genotype 1 is almost exclusively present in Romanian patients with chronic
hepatitis C. J Gastrointestin Liver Dis. 2009 Mar;18(1):45-50. PubMed PMID:
19337633.
27: Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ,
Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J,
Willerson JT, Glynn RJ; JUPITER Study Group. Rosuvastatin to prevent vascular
events in men and women with elevated C-reactive protein. N Engl J Med. 2008 Nov
20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9. PubMed PMID:
18997196.
28: Ciurtin C, Cojocaru VM, Miron IM, Preda F, Milicescu M, Bojincă M, Costan O,
Nicolescu A, Deleanu C, Kovàcs E, Stoica V. Correlation between different
components of synovial fluid and pathogenesis of rheumatic diseases. Rom J Intern
Med. 2006;44(2):171-81. PubMed PMID: 17236298.
29: Martin A, Bojincă M, Milicescu M, Macovei L, Stoian S, Suţeanu S, Stoica V. A
Romanian instrument to facilitate bone density measurement indication in
postmenopausal women. Rom J Intern Med. 2004;42(4):695-708. PubMed PMID:
16366141.

Rezumatele unor postere sau prezentari orale publicate in reviste cu ISSN sau ISBN

[Type text]
1. A. Răşanu, S. Aramă, F. Pop, M. Bojincă, V. Stoica. Gastric patological aspects in rheumatoid arthritis. Poster la : An-
nual European Congress of Rheumatology, Amsterdam, Netherlands, 21-24 june 2006, publicat în Annals of The
Rheumatic Diseases - Scientific Abstracts from the EULAR 2006, pag 630, ISSN 0003-4967 (revistă indexată ISI)
2. A. Răşanu, O. Gheorghe-Fronea, S. Aramă, F. Pop, C. Cocoşilă, M. Bojincă, V. Stoica. Gastroduodenal injuries in
collagen diseases patients: a case-control study. Poster la : Annual European Congress of Rheumatology, EULAR
2007, Barcelona, 13-16 June 2007, publicat în Annals of The Rheumatic Diseases - Scientific Abstracts from the EU-
LAR 2007, pag 596, ISSN 0003-4967 (revistă indexată ISI)
3. Bojinca, V; Bojinca, M; Balanescu, A; Ionescu, R; Predeteanu, D, The effect of estrogen analog treatment on bone
mineral density in men with prostate cancer - DXA and calcanean ultrasound evaluation. ANNALS OF THE
RHEUMATIC DISEASES, 63, p. 451, 2004.
4. Ciurtin, CS; Costan, O; Cojocaru, V; Bojinca, M; Deleanu, C; Kovacs, E, Characterisation of complex metabolic
environment of synovial fluid - Relation to the pathogenesis of rheumatoid diseases. ANNALS OF THE RHEUMATIC
DISEASES, 64, p. 144, 2005.
5. Ciurtin, CS; Costan, O; Cojocaru, V; Deleanu, C; Kovacs, E; Bojinca, M, Proton magnetic resonance spectroscopy
analysis of synovial fluid - A possibility to detect potential diagnostic indicators for rheumatic diseases. ANNALS OF
THE RHEUMATIC DISEASES, 63, p. 139, 2004.
Carol Davila Univ Med & Pharm, Bucharest, Romania.
6. Bojinca, M; Popa, L; Dan, L; Bordeianu, G; Cimponeriu, D; Bojinca, V, Association of HLA-DRB1 alleles with severe
rheumatoid arthritis in a group of Romanian patients. ANNALS OF THE RHEUMATIC DISEASES, 62, p. 368, 2003.
7. Milicescu, MF; Martin, AE; Bojinca, M; Milicescu, S; Bojinca, V; Stoica, V; Suteanu, S, Risk factors in glucocorticoid-
induced osteoporosis. ANNALS OF THE RHEUMATIC DISEASES, 64, p. 352, 2005.
8. Bojinca, V; Grigorie, D; Neacsu, E; Bojinca, M; Predeteanu, D; Ionescu, R; Popescu, E, Serum osteoprotegerin,
osteocalcin and crosslaps levels in patients with prostate cancer treated with estrogen agonists or antiandrogens -
Correlations with bone mineral density. ANNALS OF THE RHEUMATIC DISEASES, 62, p. 321, 2003.
9. Bojinca, M.; Bojinca, V.; Milicescu, M.; Martin, A.; Ciurtin, C.; Rasanu, A.; Micu, S.; Stoica, V., Functional status and
pain level in patients with chronic low back pain before and after standardised exercise program. ANNALS OF THE
RHEUMATIC DISEASES, 65, pp. 237-238, 2006.
10. Bojinca, M.; Bojinca, V.; Bida, D.; Mihai, C. M.; Milicescu, M., Spinal stenosis - complication of osteoporotic vertebral
fractures. OSTEOPOROSIS INTERNATIONAL, 18, pp. S42-S43, 2007.
11. Bojinca, V; Bojinca, M; Balanescu, A; Berghea, F; Constantinescu, C; Negru, M; Opris, D; Predeteanu, D; Ionescu,
R, Ultrasound assessment of osteoporosis prevalence and correlation with osteoporotic fractures in a group of 2273
women from Bucharest, Romania. ANNALS OF THE RHEUMATIC DISEASES, 64, p. 352, 2005.
12. Bojinca, M.; Bojinca, V.; Bida, D.; Mihai, C. M.; Milicescu, M.; Stoica, V., Exercise program with the huber system
compared with classic exercise program for patients with chronic low back pain. OSTEOPOROSIS INTERNATIONAL,
18, p. S42, 2007.
13. Ciurtin, C.; Cojocaru, V.; Miron, I.; Preda, F.; Nicolescu, A.; Deleanu, C.; Micu, S.; Milicescu, M.; Bojinca, M.; Stoica,
V.; Kovacs, E., Quantification of citrulline and ceramide levels in rheumatoid arthritis synovial fluid by proton magnetic
resonance spectroscopy. ANNALS OF THE RHEUMATIC DISEASES, 65, pp. 127-128, 2006.
14. Bojinca, V.; Bojinca, M.; Balanescu, A.; Opris, D.; Berghea, F.; Predeteanu, D.; Ionescu, R., Screening for
osteoporosis with calcanean quantitative ultrasound (QUS) in a group of postmenopausal women less than 50 years.
OSTEOPOROSIS INTERNATIONAL, 18, p. S43, 2007.
15. Bojinca, V; Grigorie, D; Neacsu, E; Bojinca, M; Balanescu, A; Ionescu, R; Predeteanu, D; Popescu, E, Serum
osteoprotegerin, osteocalcin and urinary deoxypiridinoline levels in patients with prostate cancer treated with estrogen
agonists or antiandrogens - Correlations with bone mineral density assessed by DXA and ultrasonography of the
calcaneum. OSTEOPOROSIS INTERNATIONAL, 14, p. S40, 2003.
16. Balanescu, Andra; Bojinca, Mihai; Bumbacea, Dragos; Pravu, Magda; Enache, Camelia; Bojinca, Violeta; Opris,
Daniela; Berghea, Florian; Martin, Andrei; Ancuta, Ion; Milicescu, Mihaela; Udrea, Gabriela; Stoica, Victor;
Tanasescu, Coman; Predeteanu, Denisa; , Tuberculosis in rheumatoid arthritis patients treated with infliximab - The
Romanian experience.. ARTHRITIS AND RHEUMATISM, 54 (9), p. S405, 2006.
17. Popa, O. M.; Dutescu, M. I.; Bojinca, M.; Bojinca, V.; Bara, C.; Meirosu, M.; Milicescu, M.; Popa, L. O., The influence
of TNF-alpha polymorphisms on the susceptibility and severity of ankylosing spondylitis in Romanian patients.
TISSUE ANTIGENS, 77 (5), pp. 506-507, 2011.
18. Ionitescu, R. C.; Popa, G. H.; Mihai, C.; Potorac, R.; Sfrent-Cornateanu, R.; Bojinca, M.; Stoica, V., FINGERPRINT
EVALUATION IN SYSTEMIC SCLEROSIS. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 28 (2), p. S116,
2010.
19. Ionitescu, R. C.; Bojinca, M.; Ion, A.; Sasu, M.; Macovei, L.; Mogos, C.; Tanaseanu, S.; Pompilian, V.; Baicus, C.;
Predeteanu, D.; Sfrent-Cornateanu, R.; Ionescu, R.; Stoica, V., Cross-sectional study in systemic sclerosis.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 27 (3), pp. 31-, 2009.
20. Ionitescu, S. C.; Mihai, C.; Bojinca, M.; Sfrent-Cornateanu, R.; Ion, A.; Macovei, L.; Manea, O.; Sasu, M.; Ancuta, I.;
Milicescu, M.; Mogosan, C.; Abobului, M.; Berghea, F.; Predeteanu, D.; Ionescu, R.; Stoica, V., SIMVASTATIN IN
SYSTEMIC SCLEROSIS PATIENTS - AN OPEN-LABEL STUDY. CLINICAL AND EXPERIMENTAL
RHEUMATOLOGY, 28 (2), p. S158, 2010.
21. Ionitescu, R. C.; Sfrent-Cornateanu, R.; Mihai, C.; Bojinca, M.; Macovei, L.; Ciofu, C.; Mogosan, C.; Manea, O.; Sasu,
M.; Ancuta, I.; Tanascanu, S.; Baicus, C.; Dragoescu, O.; Abobului, M.; Predetean, D.; Ionescu, R.; Stoica, V.,
[Type text]
 RAISED INTERLEUKIN-4 AND INTERLEUKIN-17 SERUM LEVELS IN PATIENTS WITH SYSTEMIC SCLEROSIS.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 28 (2), pp. S133-S134, 2010.
22. Pop V, Ciurtin C, Florea I, Stoian S, Negru E, Ioacara S, Chircu J, Milicescu M, Teodorescu D, Visan R, Arama S,
Macovei L, Bojinca M, Suteanu S, Stoica V. Corticoid therapy tolerability in rheumatoid poliartritis – a clinical study on
196 patients. Poster at The National Congress of Rheumatology, Craiova, Romania, September 15-18, 2004
23. A. Răşanu, S.S. Aramă, O. Gheorghe-Fronea, C. Cocoşilă, S. Micu, M. Bojincă, V. Stoica. Afectarea tubului digestiv
superior în bolile de colagen : studiu caz –control. Poster la Congresul Naţional de Reumatologie, Braşov, 18 - 21 oct.
2006, cu rezumat publicat în Revista Româna de Reumatologie, vol XV, nr 2-3, 2006, pag 110-111
24. Alina Răşanu, Oana Gheorghe-Fronea, S. S. Aramă, Sînziana Micu, M. Bojică, V. Stoica. Studiu comparativ asupra
manifestărilor esogastroduodenale din bolile de colagen. Poster la Congresul Naţional de Reumatologie, Braşov, 18 -
21 oct. 2006, cu rezumat publicat în Revista Româna de Reumatologie, vol XV, nr 2-3, 2006, pag. 111
25. S. Aramă, Alina Răşanu, M. Bojincă, V. Stoica. Afectarea digestivă superioară în bolile de colagen – comunicare
orală la Zilele medicale ale Spitalului ”Dr. I. Cantacuzino”, Bucureşti, 23-24 noiembrie 2006
26. A. Răşanu, S. Aramă, M. Bojincă, V. Stoica. Strategii diagnostice privind afectarea tractului digestiv la pacienţii cu boli
de colagen – comunicare orală la Zilele medicale ale Spitalului ”Dr. I. Cantacuzino”, Bucureşti, 23-24 noiembrie 2006
27. C. Ciurtin, M. Cojocaru, S. Micu, I. Dimofte, S. Aramă, M. Bojincă, V. Stoica. Defecte genetice de sinteză a
colagenului fără afectare morfometrică – două prezentări de cazuri. Prezentare de caz la Al VIII-lea Congres Naţional
de Medicină Internă, 9-12 aprilie 2008, Călimăneşti-Căciulata, cu rezumatul publicat în Medicina Internă 2008; 2 (7),
p. 107, ISSN: 1220-5818.
28. AB0565 (2008)
CROSS-SECTIONAL STUDY IN SYSTEMIC SCLEROSIS
R.C. Ionitescu1, M. Bojinca1, A. Ion1, M. Sasu1, L. Macovei1, C. Mogos1, S. Tanaseanu2, V. Pompilian2, C.
Baicus2, D. Predeteanu3, R. Sfrent-Cornateanu4, R. Ionescu3, V. Stoica1
SAT0385 (2008)
29 EXERCISE PROGRAM WITH THE HUBER® SYSTEM IS EFFECTIVE IN PATIENTS WITH CHRONIC,
UNCOMPLICATED, LOW BACK PAIN
M. Bojinca1, V. Bojinca2, C. Mihai1, D. Bida1, M. Milicescu1, R. Cornea3, V. Stoica1
30. SAT0445 (2008)
WHY RHEUMATIC PATIENTS DO BETTER IN CLINICAL TRIALS THAN IN REAL LIFE?
M. Marinescu1, F. Berghea2, C. Mihai3, A. Biro4, M. Bojinca3, M. Milicescu3, A. Ion3, H. Popoviciu4, A. Balanescu2, D.
Opris2, R. Ionescu2

EULAR
2018
2018 Characterisation and comparison of serum biomarkers in patients with rheumatoid arthritis versus
AB0109 osteoarthritis using mass spectrometry,
A. Circiumaru, C. Butnaru, M. Bojinca, S. Petrescu

2018 Pathologic musculoskeletal ultrasound findings in patients with chronic kidney disease on dialysis-
AB1042 a pilot controlled study,
R.D. Decianu, M. Bojinca, C.A. Capusa, A. Zugravu, V.C. Bojinca

2018 Bone mineral density and t-score evaluation in a group of patients with rheumatoid arthritis using a
AB1214 new ultrasound method: echos – genodynamic - a pilot study –,
R.D. Decianu, M. Bojinca, S. Daia-Iliescu, D. Mazilu, M.M. Negru, A.R. Balanescu, D. Opris- Belinski, R.
Ionescu, V.C. Bojinca

2018 Risk factors for postpartum flare in rheumatoid arthritis – a romanian cohort,
FRI0054 A. Bobirca, F. Bobirca, I. Ancuta, M. Micu, C. Ancuta, M. Bojinca, C. Mihai, V. Stoica

2018 Predictors for the response to anti-tnf therapy and the impact of smoking in rheumatoid arthritis-
FRI0104 results on a group of patients in romania,
B.I. Gavrila, C.S. Ciofu, L. Macovei, A.M. Gheorghiu, M. Sasu, C. Mihai, V. Stoica, I. Ancuta, M. Bojinca

2018 Mean number of capillaries is associated with disease activity at 6 months follow-up in systemic
FRI0428 sclerosis patients,
A.M. Gheorghiu, R. Oneata, A. Radu, A. Briceag, C. Draganescu, C. Vranceanu, S. Magda, T.
Constantinescu, A. Soare, R. Dobrota, I. Ancuta, C. Ciofu, L. Macovei, M. Milicescu, M. Sasu, A. Enuica, O.
Linte, G. Stan, B. Comanescu, T. Necsoiu, M. Bojinca, V.

2018 Is ultrasound remission achievable in patients with early rheumatoid arthritis?,

SAT0672 T. Serban, I. Azzolin, I. Satulu, C.M. Mihai, G. Massazza, M. Bojinca, A. Iagnocco

[Type text]
 Bojinca, M.
[44]
2017
2017 CARTILAGE OLIGOMERIC MATRIX PROTEIN, A BIOMARKER OF ARTHRITIS, COULD BE
AB0376 USEFUL FOR PREDICTING THE RESPONSE TO BIOLOGIC THERAPY IN RHEUMATOID
ARTHRITIS? ,
B.I. Gavrila, C. Ciofu, C. Mihai, G. Udrea, M. Bojinca, V. Stoica, E. Panaitescu

2017 PREGNANCY IN RHEUMATOID ARTHRITIS – A ROMANIAN COHORT ,

AB0294 A. Bobirca, F. Bobirca, I. Ancuta, C. Mihai, C. Tataru, C. Comsa, M. Bojinca, M. Micu, A. Musetescu,
C. Ancuta, V. Stoica

2017 PREDICTIVE FACTORS FOR LONG-TERM SURVIVAL AND DISEASE PROGRESSION OF

AB0608 SYSTEMIC SCLEROSIS – A LONGITUDINAL ANALYSIS ,
A.M. Gheorghiu, A. Radu, R. Oneata, A. Soare, R. Dobrota, S. Magda, T. Constantinescu, R. Jurcut,
R. Sfrenţ-Cornăţeanu, M. Bojincă, V. Stoica, C. Mihai

2017 A PROPOSAL FOR A SIMPLE ULTRASOUND METHOD FOR THE DIAGNOSIS OF EARLY
FRI0676 RHEUMATOID ARTHRITIS ,
T. Serban, I. Satulu, O. Vutcanu, M. Milicescu, C.M. Mihai, M. Bojinca

2017 RISK OF ACTIVE TUBERCULOSIS IN PATIENTS WITH INFLAMMATORY ARTHRITIS

SAT0681 RECEIVING TNF-INHIBITORS ,
A.M. Gheorghiu, A. Garaiman, A. Radu, A. Soare, V. Aramă, D. Bumbăcea, R. Dobrotă, R. Oneata,
S. Pintilie, M. Milicescu, I. Ancuta, A. Martin, M. Sasu, C. Ciofu, L. Macovei, V. Stoica, M. Bojinca, C.
Mihai

2017 THE INFLUENCE OF OSTEOARTHRITIS ON CLINICAL, LABORATORY AND ULTRASOUND

SAT0547 PARAMETERS OF PATIENTS WITH EARLY RHEUMATOID ARTHRITIS ,
T. Serban, I. Satulu, O. Vutcanu, M. Milicescu, C.M. Mihai, M. Bojinca

2017 RISK FACTORS FOR EARLY RETIREMENT IN SYSTEMIC SCLEROSIS ,

THU0607 A.M. Gheorghiu, C. Vrancianu, C. Draganescu, R. Oneata, L. Macovei, M. Sasu, M. Milicescu, O.
Olteanu, M. Speriatu, M. Bojincă, V. Stoica, C. Mihai

2017 NAILFOLD CAPILLAROSCOPY CHANGES REFLECT ENDOTHELIAL ACTIVATION AND

FRI0368 INJURY IN PATIENTS WITH SYSTEMIC SCLEROSIS ,
A.M. Gheorghiu, R. Sfrent-Cornateanu, D. Marta, M. Bojinca, S. Magda, T. Constantinescu, A. Soare,
R. Dobrota, L. Macovei, V. Stoica, C. Bara, C. Mihai

2017 MODERATE TO GOOD CONSTRUCT VALIDITY OF GLOBAL PRESENTEEISM MEASURES

THU0689 WITH MULTI-ITEM PRESENTEEISM MEASURE AND PATIENT REPORTED HEALTH
OUTCOMES: EULAR-PRO WORKER PRODUCTIVITY STUDY ,
S. Leggett, A. Boonen, D. Lacaille, S. Talli, M. Bojinca, J. Karlson, D. Beaton, B. Fautrel, J. Canas da
Silva, C. Hoffstetter, S. Verstappen
2016
2016 EPIDEMIOLOGY OF EARLY RHEUMATOID ARTHRITIS: RESULTS FROM AN EARLY
AB1051 ARTHRITIS RESEARCH CENTER FROM ROMANIA ,
T. Serban, I. Satulu, O. Vutcanu, A. Circiumaru, M. Milicescu, C. Mihai, M. Bojinca

2016 WHAT IS THE PLACE OF CORTICOSTEROIDS IN THE TREATMENT OF PATIENTS WITH

AB0403 EARLY ARTHRITIS? ,
T. Serban, I. Satulu, O. Vutcanu, A. Circiumaru, M. Milicescu, C. Mihai, M. Bojinca

2016 PERFORMANCE OF THE 2013 AMERICAN COLLEGE OF RHEUMATOLOGY/EUROPEAN

THU0603 LEAGUE AGAINST RHEUMATISM SYSTEMIC SCLEROSIS CLASSIFICATION CRITERIA ,
A.M. Gheorghiu, R. Dobrota, T. Predescu, L. Grigorescu, A. Soare, M. Gorga, R. Ionitescu, R. Jurcut,
S. Magda, T. Constantinescu, R. Sfrenţ-Cornăţeanu, M. Bojinca, V. Stoica, C. Mihai

2016 RELIABILITY, VALIDITY, AND SENSITIVITY TO CHANGE OF THE DURUOZ HAND INDEX IN
SAT0211 SYSTEMIC SCLEROSIS* ,
A.M. Gherghe, H. Gyorfi, R. Capota, A. Matei, R. Oneata, M. Milicescu, L. Macovei, M. Sasu, M.
Bojinca, V. Stoica, C. Mihai

[Type text]
 2015
2015 IS THE QUANTITATIVE ASSESSMENT OF POWER DOPPLER CONTINUOUS LOOP SUPERIOR
AB1052 TO SINGLE FRAME EVALUATION IN MSUS? ,
F. Berghea, V. Vlad, M. Bojinca, F. Vreju, M. Copotoiu, A. Borangiu, L. Palanciuc, L. Varzaru, T.
Mazdrag, D. Stanciu, M. Abobului, A. Kosevoi, V. Bojinca, D. Opris, A. Balanescu, D. Predeteanu, R.
Ionescu

2015 TYPE OF PERSONALITY – A NEW ITEM TO TAKE INTO ACCOUNT WHEN EVALUATING
AB1224- QUALITY OF LIFE AND DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS (RA) PATIENTS ,
HPR M.A. Dobrin, T. Donisan, D. Predeteanu, V.C. Bojinca, C. Constantinescu, M. Bojinca, D. Opris, L.
Groseanu, A. Borangiu, M. Negru, F. Berghea, D.V. Balanescu, R. Ionescu, A.R. Balanescu

2015 CORRELATIONS BETWEEN PERSONALITY TYPES, DISEASE ACTIVITY AND QUALITY OF

AB1227- LIFE IN ANKYLOSING SPONDYLITIS (AS) PATIENTS (PTS) ,
HPR T. Donisan, M.A. Dobrin, D. Predeţeanu, V.C. Bojincă, M. Bojincă, C.L. Constantinescu, D. Opriş, L.
Groşeanu, A. Borangiu, F. Berghea, D.V. Bălănescu, R. Ionescu, A.R. Bălănescu

2015 ACTIVE TUBERCULOSIS IN ARTHRITIS PATIENTS RECEIVING TNF INHIBITORS DESPITE

SAT0330 BASELINE SCREENING ,
A. Soare, A.M. Gherghe, R. Dobrota, S. Pintilie, R. Oneata, I. Ancuta, M. Milicescu, A. Martin, M.
Sasu, C. Ciofu, L. Macovei, V. Stoica, M. Bojinca, C. Mihai

2015 INCREASED INCIDENCE OF TUBERCULOSIS AMONG SYSTEMIC LUPUS ERYTHEMATOSUS

THU0331 PATIENTS – SHOULD TUBERCULOSIS SCREENING AT DIAGNOSIS BE THE NEXT STEP? ,
A.M. Gherghe, A. Matei, H. Györfi, A. Soare, R. Dobrota, M. Sasu, L. Macovei, I. Ancuta, C. Ciofu, M.
Milicescu, M. Bojinca, V. Stoica, C. Mihai

2015 RHEUMATOID ARTHRITIS AND PREGNANCY IN ROMANIAN FEMALES ,

THU0131 A. Boca, I. Ancuta, M. Micu, R. Popescu, C. Tataru, C. Comsa, M. Bojinca, C. Mihai, C. Ancuta, V.
Stoica
2014
2014 COMPARISON OF TWO REFERRAL STRATEGIES FOR THE DIAGNOSIS OF AXIAL
AB0684 SPONDYLOARTHRITIS IN ROMANIA: THE RADAR STUDY ,
C.M. Ancuta, C. Pomirleanu, D. Opris, R. Chirieac, C. Codreanu, M. Bojinca, S. Rednic, R. Ionescu

2014 PREVENTING ACTIVE TUBERCULOSIS IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING

THU0413 TNF INHIBITORS: TB SCREENING AT BASELINE IS NOT ENOUGH ,
A. Soare, C. Mihai, A.M. Gherghe, R. Dobrota, S. Pintilie, M. Milicescu, I. Ancuta, A. Martin, L.
Macovei, C. Ciofu, M. Sasu, V. Stoica, M. Bojinca

2014 THE DYNAMICS OF RESPONSE TO RITUXIMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH

FRI0321 MODERATE DISEASE ACTIVITY AND INADEQUATE RESPONSE TO INHIBITORS OF TUMOR
NECROSIS FACTOR. DATA FROM 3-YEAR REPEAT STUDY ,
I. Ancuta, C. Codreanu, R. Ionescu, A. Balanescu, E. Rezus, M. Suta, P. Ciurea, M. Milicescu, D.
Nemes, C. Ancuta, M. Bojinca, M. Parvu, H. Popoviciu

2014 SUSTAINED CLINICAL BENEFIT WITH MULTIPLE COURSES OF RITUXIMAB IN SECOND LINE
SAT0228 FOR ALL RHEUMATOID ARTHTRITIS PATIENTS IRRESPECTIVE TO THE INHIBITOR OF
TUMOUR NECROSIS FACTOR PREVIOUSLY USED: 3-YEAR DATA FROM REPEAT STUDY ,
I. Ancuta, C. Codreanu, R. Ionescu, A. Balanescu, E. Rezus, M. Suta, P. Ciurea, M. Milicescu, D.
Nemes, C. Ancuta, M. Bojinca, M. Parvu, H. Popoviciu

2014 CORRELATION BETWEEN TIME TO SWITCH AND CLINICAL RESPONSE AMPLITUDE TO

THU0261 RITUXIMAB IN SECOND LINE TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS WITH
TREATMENT FAILURE TO TUMOR NECROSIS FACTOR INHIBITORS: 3-YEAR DATA FROM
REPEAT OBSERVATIONAL STUDY ,
I. Ancuta, C. Codreanu, R. Ionescu, A. Balanescu, E. Rezus, M. Suta, P. Ciurea, M. Milicescu, D.
Nemes, C. Ancuta, M. Bojinca, M. Parvu, H. Popoviciu
2013
2013 PATTERNS OF CLINICAL RESPONSE PREDICT FAILURE OF TNF INHIBITOR TREATMENT IN
THU0162 RHEUMATOID ARTHRITIS: DATA FROM A LONGITUDINAL OBSERVATIONAL STUDY IN
ROMANIA ,

[Type text]
 I. Ancuta, C. Codreanu, R. Ionescu, M. Parvu, M. Bojinca

2013 DISEASE FLARES PREDICT THE CHANGE TO SECOND LINE THERAPY IN RHEUMATOID
THU0163 ARTHRITIS: 9-YEAR DATA FROM A LONGITUDINAL OBSERVATIONAL STUDY ,
I. Ancuta, C. Codreanu, R. Ionescu, M. Parvu, M. Bojinca

2013 A DIRECT COMPARISON OF WEB-BASED AND REAL-LIFE ULTRASOUND ASSESSMENTS OF

AB0759 RHEUMATOID ARTHRITIS HANDS INVOLVING THE SAME ULTRASONOGRAPHERS ,
V. Vlad, M. Micu, L. Varzaru, M. Bojinca, M. Milicescu, F. Berghea, D. Predeteanu, R. Ionescu
2012
2012 SUPERIOR LOW DISEASE ACTIVITY AND REMISSION RATES WHEN RITUXIMAB IS INITIATED
AB0537 AFTER THE FIRST ANTI-TNF FAILURE: REAL LIFE DATA ,
I. Ancuta, C. Codreanu, R. Ionescu, M. Parvu, M. Bojinca

2012 SUSTAINED AND CUMULATED RESPONSE OVER TIME IN RA PATIENTS TREATED WITH
OP0026 RITUXIMAB AFTER INITIAL FAILURE OF ANTI-TNF AGENTS ,
I. Ancuta, C. Codreanu, R. Ionescu, M. Parvu, M. Bojinca

2012 WHY DO WE MAKE DIAGNOSTIC ERRORS? A DELPHY EXERCISE TO IDENTIFY POTENTIAL

SAT0453 CAUSES OF DIAGNOSTIC ERRORS ,
C. Rosca, F. Berghea, C. Constantinescu, M. Abobului, V. Vlad, I. Saulescu, L. Groseanu, M. Negru,
D. Opris, V. Bojinca, M. Bojinca, A. Balanescu, D. Predeteanu, R. Ionescu

2012 RITUXIMAB AFTER FIRST ANTI-TNF FAILURE IS MORE EFFICIENT WITH HIGH IMPACT IN
THU0106 REDUCING TIME AND COSTS TO ACHIEVE SUPERIOR RATES OF LOW DISEASE ACTIVITY
AND REMISSION ,
I. Ancuta, C. Codreanu, R. Ionescu, M. Parvu, M. Bojinca
2011
2011 DISCRIMINATIVE CAPACITY OF NAILFOLD CAPILLAROSCOPY FOR SECONDARY
AB0073 RAYNAUD'S PHENOMENON ,
A.M. Gherghe, C. Mihai, E. Giurescu, R. Ioniţescu, O. Drăghicescu Manea, A. Comărniceanu, M.
Milicescu, R. Sfrenţ-Cornăţeanu, D.-C. Ene, L. Căloiu, L. Macovei, M. Bojincă, V. Stoica

2011 CARDIOVASCULAR RISK IN ANKYLOSING SPONDYLITIS – A COMPARISON OF REAL-LIFE

AB0144 ANKYLOSING SPONDYLITIS AND RHEUMATOID ARTHRITIS PATIENT COHORTS ,
A. Comarniceanu, C. Mihai, R. Jurcut, A.M. Gherghe, C. Mogosan, I. Ancuta, M. Milicescu, L.
Macovei, S. Deaconu, D. Sayed, J. Szekely, S. Popa, M. Bojinca, V. Stoica

2011 COST OF ILLNESS IN A COHORT OF RHEUMATOID ARTHRITIS PATIENTS IN ROMANIA ,

THU0049 C. Mogosan, C. Mihai, A. Boonen, L. Macovei, I. Ancuta, M. Bojinca, A. Martin, V. Crisan, C. Zainea,
D. Marculescu, C. Codreanu, V. Stoica

[Type text]